---
title: Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate
  the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome
  (IBS)
date: '2022-06-10'
linkTitle: http://link.springer.com/10.1007/s11306-022-01900-z
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Functional
  gastrointestinal disorders (FGID) such as functional dyspepsia (FD) and irritable
  bowel syndrome (IBS) are highly prevalent and debilitating attributed to altered
  gut function and gut-brain interactions. FGID can be reliably diagnosed based upon
  the symptom pattern; but in the clinical setting FD or IBS a frequent diagnoses
  of exclusion after relevant structural causes of symptoms have been ruled out by
  appropriate testing. Thus far, there is no established biomarker for FGIDs. To address
  this limitation, we utilised ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Functional gastrointestinal disorders (FGID) such as functional dyspepsia (FD) and irritable bowel syndrome (IBS) are highly prevalent and debilitating attributed to altered gut function and gut-brain interactions. FGID can be reliably diagnosed based upon the symptom pattern; but in the clinical setting FD or IBS a frequent diagnoses of exclusion after relevant structural causes of symptoms have been ruled out by appropriate testing. Thus far, there is no established biomarker for FGIDs. To address this limitation, we utilised ...